Invivogen
Menu

Human IL-1α & IL-1β Reporter HEK 293 Cells

Product Unit size Cat. code Docs. Qty. Price

HEK-Blue™ IL-1β Cells

HEK 293 reporter cells for human and murine IL-1β cytokines

Show product

3-7 x 10e6 cells

hkb-il1bv2
+-
$1,457

HEK-Blue™ IL-1β vial

Additional cell vial

Show product

3-7 x 10e6 cells

hkb-il1bv2-av
+-

Notification:  Reference #hkb-il1bv2-av can only be ordered together with reference #hkb-il1bv2.

Human IL-1 Reporter Cells

Signaling pathway in HEK-Blue™ IL-1β cells
Signaling pathway in HEK-Blue™ IL-1β cells

HEK-Blue™ IL-1β cells  were engineered from the human embryonic kidney HEK293 cell line to detect bioactive human interleukin-1 β (IL-1β) in various biological samples (cell culture supernatant and serum) by monitoring the activation of the NF-κB and AP-1 pathways. These cells are useful to monitor IL-1β secretion in inflammasome activation studies. Additionally, HEK-Blue™ IL-1β detect bioactive human IL-1α. Both IL‑1α and IL-1β are secreted pro‑inflammatory cytokine that play a critical role in immune responses and inflammation [1].

More details More details

 

Cell line description:

HEK-Blue™ IL-1β cells endogenously express the human (h) IL-1 receptor, which binds both IL-1α and IL-1β. They were transfected with a NF-κB/AP-1-inducible secreted embryonic alkaline phosphatase (SEAP) reporter. The binding of IL-1α or IL-1β to its receptor triggers a signaling cascade leading to NF-κB/AP-1 activation and the subsequent production of SEAP. This can be readily assessed in the supernatant using QUANTI-Blue™ Solution, a SEAP detection reagent.

HEK-Blue™ IL-1β cells respond to hIL-1α and hIL-1β (see figures). They also respond to a lesser extent to murine (m) IL-1α and mIL-1β (see figures). The specificity of the HEK-Blue™ IL-1β cells for the detection of IL-1α or IL-1β can be confirmed using a neutralizing antibody against human IL-1α or IL-1β, such as anti-hIL-1α-IgG and anti-hIL-1β-IgG. Of note, these cells do no respond to hTNF-α or mTNF-α (see figures).

Key features:

  • Fully functional IL-1β signaling pathway
  • Readily assessable NF-κB/AP-1-inducible SEAP reporter activity
  • Do not respond to human or murine TNF-α

Applications:

  • Detection of human IL-1β, and to a lesser extent murine IL-1β
  • Detection of IL-1β in inflammasome studies
  • Screening of anti-IL-1β antibodies

 

HEK-Blue™ IL-1β and HEK-Blue™ IL-1R cells
  • HEK-Blue™ IL-1β cells are more sensitive to human IL-1 isoforms than murine isoforms. We recommend using this cell line to test supernatant from human inflammasome cellular assays.
  • HEK-Blue™ IL-1R cells are stably transfected to additionally express the murine IL-1R, conferring a higher sensitivity to mIL-1α and mIL-1β, when compared to HEK-Blue™ IL-1β cells.

 

Learn more on SARS-CoV-2Download our Practical guide on Inflammasomes

 

Reference:

1. Dinarello C., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281(1): 8–27. 

Figures

Response of HEK-Blue™ IL-1β cells to recombinant IL-1β
Response of HEK-Blue™ IL-1β cells to recombinant IL-1β

Stimulation of HEK-Blue™ IL-1β cells by recombinant human and murine IL-1β. After a 24 h incubation, SEAP activity was assessed using QUANTI-Blue™ Solution and reading the optical density (O.D.) at 630 nm.

Response of HEK-Blue™ IL-1β cells to recombinant IL-1α
Response of HEK-Blue™ IL-1β cells to recombinant IL-1α

Stimulation of HEK-Blue™ IL-1β cells by recombinant human and murine IL-1α. After a 24 h incubation, SEAP activity was assessed using QUANTI-Blue™ Solution and reading the optical density (O.D.) at 630 nm.

HEK-Blue™ IL-1β specificity
HEK-Blue™ IL-1β specificity

Specific response of HEK‑Blue™ IL ‑1β cells to IL‑1β and IL‑ 1α cytokines.

Cells were stimulated with 1 ng/ml of hIL‑1β, mIL-1β, hIL-1α, mIL-1α, 100 ng/ml of hTNF-α, mTNF-α, ultrapure flagellin from S. typhimurium (FLA-ST UP) or 300 ng/ml of Poly(I:C) HMW. After overnight incubation, SEAP activity was assessed using QUANTI‑Blue™ Solution. OD at 630 nm is shown as mean ± SEM.

Human IL-1β signaling inhibition
Human IL-1β signaling inhibition

Dose‑dependent inhibition of HEK‑Blue™ IL‑1β cellular response using a neutralizing antibody against hIL‑1β. The anti-hIL1β antibody was incubated with the cells for 30 minutes prior to the addition of hIL-1β (1 ng/ml). After overnight incubation, SEAP activity in the cell culture supernatant was assessed using QUANTI-Blue™ Solution. Data represent % of maximal reporter activity without the anti-hIL1β antibody.

Back to the top

Specifications

Antibiotic resistance: Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-Glutamine, 10% (v/v)  heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml Normocin™

Guaranteed mycoplasma-free

Detects human and murine IL-1β (α)

  • Detection range for human IL-1β: 100 pg - 100 ng/ml
  • Detection range for murine IL-1β: 10 ng - 1 µg/ml

 

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

  • 1 vial containing 3-5 x 106 cells
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

dry ice Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Back to the top

Details

IL-1β is a soluble pro-inflammatory cytokine that plays a critical role in the host response to infection and injury [1]. It is synthesized as a pro-IL-1β zymogen by activated macrophages and must be cleaved by caspase-1 to generate its mature form [2]. IL-1β binding to the IL-1R1 receptor triggers the formation of the IL-1R1/IL-1R3/MyD88 complex and induces signaling leading to the activation of the transcription factors NK-κB and AP-1 [3]. Due to its role in mediating acute and chronic inflammation, IL-1β has emerged as a therapeutic target for auto-inflammatory diseases [1,4]. 

 

1. Dinarello C., 2018. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 281(1): 8–27. 
2. Lopez-Castejon G. & Brough D., 2011. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 22(4):189-95.
3. Weber A. et al., 2010. Interleukin-1 (IL-1) pathway. Sci Signal. 3(105):cm1.
4. Dinarello CA., 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720–3732.

 

THP-1/HEK-Blue™ IL-1β Assay

Production of IL-1β by THP-1 cells

1. Production of IL-1β by THP-1 cells. Typically, THP-1 cells are pre-treated with phorbol 12-myristate acetate (PMA) to become more susceptible to inflammasome activators, then are primed with lipopolysaccharide (LPS). These treatments induce the production of pro-IL-1β, the immature form of IL-1β. Subsequent stimulation with inflammasome inducers, such as ATP, leads to NRLP3 and caspase-1 activation resulting in IL-1β maturation and secretion.

 

Detection of IL-1β by HEK-Blue™ IL-1β cells

2. Detection of IL-1β by HEK-Blue™ IL-1β cells. IL-1β-containing THP-1 supernatants are added to HEK-Blue™ IL-1β cells leading to NF-κB activation and the subsequent production of SEAP. The presence of SEAP in HEK-Blue™ IL-1β supernatants is assessed using QUANTI-Blue™ Solution, a SEAP detection medium.

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top

Notification: : This cell line has been replaced with another clone which is KO for TLR3, TLR5, and TNFR1. Thus, it has a new cat. code: hkb-il1bv2.
This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty